Imaging Intelligence Daily
Tuesday, March 31, 2026
Issue #19 · 6 signals
🔵 RESEARCH
Study Finds Paramedics Accept Tele-Guided Lung Ultrasound in Field
TULIP study assessed paramedic acceptability of remotely guided point-of-care lung ultrasound for prehospital respiratory emergencies.
This is an acceptability study, not a diagnostic accuracy trial — it validates willingness, not clinical outcomes. POCUS vendors eyeing EMS markets should watch for follow-up performance data before claiming pre-hospital utility. This follows a separate study validating paramedic-performed ultrasound published the same day.
Journal of imaging informatics in medicine · 2026-03-30   Read more →
🔵 RESEARCH
Trial Tests Portable Ultrasound for Breast Screening in LMICs
Clinical trial launched evaluating AI-assisted point-of-care ultrasound for breast cancer diagnosis in low- and middle-income countries.
Trial registration alone provides no sensitivity or specificity data versus mammography. Still, it signals commercial validation for portable ultrasound vendors like Butterfly and GE Vscan targeting resource-limited markets where traditional imaging infrastructure is absent.
ClinicalTrials.gov · 2026-03-30   Read more →
🔵 RESEARCH
Researchers Build Standardized Benchmark for Breast Ultrasound AI
Retrospective study constructs a benchmark evaluation system for breast ultrasound AI interpretation and tests multimodal model performance.
Standardized benchmarks favor incumbents with large ultrasound datasets and installed bases. Pure-play AI startups face higher bars to prove differentiation. Watch for OEMs partnering with benchmark developers to lock in evaluation frameworks that align with their platforms.
ClinicalTrials.gov · 2026-03-30   Read more →
🔵 RESEARCH
Deep Learning Framework Harmonizes Multi-Tracer PET Across Scanners
Researchers developed a unified deep learning framework to standardize multi-tracer PET quantification across different imaging platforms for neurodegenerative disease.
Cross-platform PET variability is a major friction point for multi-site neurodegeneration drug trials. This could reduce site selection constraints and trial costs for pharma, but imaging departments should wait for vendor-embedded solutions rather than attempting in-house implementation of research-stage tools.
NPJ Digital Medicine · 2026-03-30   Read more →
⚪ INDUSTRY
Medicare Data Reveals Decade of Imaging Turnaround Time Trends
JACR study analyzed national turnaround times for Medicare office and hospital outpatient imaging from 2014 to 2023.
A decade of TAT data quantifies radiologist capacity strain and strengthens the business case for AI triage and teleradiology. Imaging leaders should use these benchmarks to justify staffing investments or workflow redesign — not just populate dashboards.
JACR · 2026-03-30   Read more →
🔴 REGULATORY
Butterfly Secures FDA Clearance for Gestational Age Ultrasound AI
Butterfly Network received FDA clearance for an AI-powered gestational age estimation tool on its handheld ultrasound platform.
This clearance builds Butterfly's software moat against hardware commoditization from GE, Philips, and Chinese entrants. Health systems should evaluate whether handheld gestational age estimates integrate cleanly into obstetric EMR workflows before deploying outside traditional ultrasound departments.
Google News: site:auntminnie.com ultrasound · Mon, 30 Ma   Read more →
✍️ EDITOR’S TAKES
🩺 EDITOR’S TAKE — FOR CLINICIANS
Point-of-care ultrasound keeps expanding into new clinical domains — prehospital, obstetric, breast — but acceptability and benchmarks precede accuracy data. Demand evidence of diagnostic performance before changing referral patterns.
📊 EDITOR’S TAKE — FOR INVESTORS
Butterfly's gestational age clearance builds a recurring-revenue software moat on commodity hardware. Meanwhile, decade-long Medicare TAT trends strengthen the ROI case for AI triage and teleradiology consolidation plays.
🏭 EDITOR’S TAKE — FOR INDUSTRY
Standardization is this week's quiet theme: PET harmonization across platforms, breast ultrasound AI benchmarks, and national TAT benchmarking all signal a market maturing from point solutions toward interoperable, measurable frameworks that favor scaled incumbents.
Imaging Intelligence Daily — Medical imaging news for professionals, investors & clinicians.

Know someone who should read this? Forward this link to subscribe free.

Browse past issues →
You're receiving this because you subscribed. Unsubscribe